Trials / Conditions / Brain Neoplasm, Primary
Brain Neoplasm, Primary
5 registered clinical trials studyying Brain Neoplasm, Primary — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 220 NCT06118723 | Jasper Gerritsen | — |
| Terminated | Tumor Hypoxia With HX4 PET in Several Diseases NCT02584400 | Maastricht Radiation Oncology | Phase 2 |
| Completed | IDH1 Peptide Vaccine for Recurrent Grade II Glioma NCT02193347 | Katy Peters, MD, PhD | Phase 1 |
| Terminated | Risk Factors for Adult-Onset Brain Tumors NCT00592865 | Vanderbilt University Medical Center | — |